A fatal case of cholestatic liver failure probably related to gemcitabine

被引：16
作者：
Coeman, DC
Verbeken, EK
Nackaerts, KL
Demedts, MG
Vansteenkiste, JF [1 ]
机构：
[1] Univ Hosp Gasthuisberg, Dept Pulmonol, Resp Oncol Unit, B-3000 Louvain, Belgium
[2] Univ Hosp Gasthuisberg, Dept Pathol, B-3000 Louvain, Belgium
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷 / 11期
关键词：
D O I：
10.1023/A:1026514527313
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1503 / 1503
页数：1
相关论文
共 7 条
  • [1] Gemcitabine - a safety review
    Aapro, MS
    Martin, C
    Hatty, S
    [J]. ANTI-CANCER DRUGS, 1998, 9 (03) : 191 - 201
  • [2] Safety profile of gemcitabine, a novel anticancer agent, in non-small cell lung cancer
    CortesFunes, H
    Martin, C
    Abratt, R
    Lund, B
    [J]. ANTI-CANCER DRUGS, 1997, 8 (06) : 582 - 587
  • [3] Veno-occlusive disease of the liver induced by gemcitabine
    Dobbie, M
    Hofer, S
    Oberholzer, M
    Herrmann, R
    [J]. ANNALS OF ONCOLOGY, 1998, 9 (06) : 681 - 681
  • [4] MAJERUS PW, 1996, GOODMAN GILMANS PHAR, P1343
  • [5] Single-agent gemcitabine versus cisplatin-etoposide: Early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer
    Manegold, C
    Bergman, B
    Chemaissani, A
    Dornoff, W
    Drings, P
    KellokumpuLehtinen, P
    Liippo, K
    Mattson, K
    vonPawel, J
    Ricci, S
    Sederholm, C
    Stahel, RA
    Wagenius, G
    vonWalree, N
    tenBokkelHuinink, W
    [J]. ANNALS OF ONCOLOGY, 1997, 8 (06) : 525 - 529
  • [6] Phase I trial of gemcitabine (Gemzar®, 24 h infusion 5-fluorouracil and folinic acid in patients with inoperable pancreatic cancer
    Oettle, H
    Pelzer, U
    Hochmuth, K
    Diebold, T
    Langrehr, J
    Schmidt, CA
    Arning, M
    Vogl, TJ
    Neuhaus, P
    Huhn, D
    Riess, H
    [J]. ANTI-CANCER DRUGS, 1999, 10 (08) : 699 - 704
  • [7] Safety profile of gemcitabine
    Tonato, M
    Mosconi, AM
    Martin, C
    [J]. ANTI-CANCER DRUGS, 1995, 6 : 27 - 32
1